Literature DB >> 20486430

Characteristics of obesity and its related disorders in China.

Wei-Ping Jia1, Chen Wang, Shan Jiang, Jie-Min Pan.   

Abstract

Obesity is a medical condition with excess body fat accumulation to the extent which leads to serious health consequences. Abdominal obesity, also known as central obesity, refers to the presence of excess fat in the abdominal area. Obesity, especially abdominal obesity, contributes to many metabolic disorders including metabolic syndrome (MetS), type 2 diabetes (T2DM) and cardiovascular diseases (CVD). The incidence of obesity has increased dramatically in recent years worldwide. In China, more than one-third of adults are overweight or obese and 10%-20% of all adults are affected by MetS. The pathogenesis underlying the abdominal obesity remains unclear. The ultimate health outcome of obesity and its related metabolic disorders haveprompted physicians to take aggressive treatments (lifestyle changes, pharmacological interventions and surgical therapies) before a serious consequence becomes clinically apparent. In this review, we discuss the prevalence, pathogenesis and clinic features of obesity in China.

Entities:  

Mesh:

Year:  2010        PMID: 20486430     DOI: 10.1016/S0895-3988(10)60025-6

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  16 in total

Review 1.  Impact of obesity on drug metabolism and elimination in adults and children.

Authors:  Margreke J E Brill; Jeroen Diepstraten; Anne van Rongen; Simone van Kralingen; John N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2012-05-01       Impact factor: 6.447

2.  Comparison of the effect of 'metabolically healthy but obese' and 'metabolically abnormal but not obese' phenotypes on development of diabetes and cardiovascular disease in Chinese.

Authors:  Deng Luo; Fang Liu; Xiaowen Li; Dechao Yin; Ziwei Lin; Hui Liu; Xuhong Hou; Chen Wang; Weiping Jia
Journal:  Endocrine       Date:  2014-10-14       Impact factor: 3.633

3.  Environmental, Dietary, and Behavioral Factors Distinguish Chinese Adults with High Waist-to-Height Ratio with and without Inflammation.

Authors:  Amanda L Thompson; Linda Adair; Penny Gordon-Larsen; Bing Zhang; Barry Popkin
Journal:  J Nutr       Date:  2015-05-06       Impact factor: 4.798

4.  Enhanced peroxisomal β-oxidation metabolism in visceral adipose tissues of high-fat diet-fed obesity-resistant C57BL/6 mice.

Authors:  Wei-Dong Xie; Hua Wang; Jin-Fang Zhang; Jian-Na Li; Yi Can; Lv Qing; Hsiang-Fu Kung; Ya-Ou Zhang
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

Review 5.  The genetics of obesity.

Authors:  Blanca M Herrera; Cecilia M Lindgren
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

6.  Evaluation of the association between the AC3 genetic polymorphisms and obesity in a Chinese Han population.

Authors:  Hairu Wang; Ming Wu; Weiguang Zhu; Jin Shen; Xiaoming Shi; Jie Yang; Qihui Zhao; Chuan Ni; Yaochu Xu; Hongbing Shen; Chong Shen; Harvest F Gu
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

7.  OSA and atherosclerosis.

Authors:  Macy Mei-Sze Lui; Mary Sau-Man
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

8.  The emerging epidemic of obesity, diabetes, and the metabolic syndrome in china.

Authors:  Jia Shen; Abhinav Goyal; Laurence Sperling
Journal:  Cardiol Res Pract       Date:  2011-09-22       Impact factor: 1.866

9.  Percent body fat is a better predictor of cardiovascular risk factors than body mass index.

Authors:  Qiang Zeng; Sheng-Yong Dong; Xiao-Nan Sun; Jing Xie; Yi Cui
Journal:  Braz J Med Biol Res       Date:  2012-04-19       Impact factor: 2.590

10.  Association between socioeconomic status and obesity in a Chinese adult population.

Authors:  Yuanyuan Xiao; Naiqing Zhao; Hao Wang; Jie Zhang; Qingfang He; Danting Su; Ming Zhao; Lixin Wang; Xinwei Zhang; Weiwei Gong; Ruying Hu; Min Yu; Gangqiang Ding; Liming Cong; Zhen Ye
Journal:  BMC Public Health       Date:  2013-04-17       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.